Prev Arrow Stocks

Perrigo Company plc ($PRGO) Stock Forecast: Down 5.0% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Perrigo Company plc?

Perrigo Company plc (PRGO) is a global healthcare supplier that develops, manufactures, and distributes over-the-counter consumer goods and pharmaceutical products. Today, the stock experienced a significant bearish movement in the market.

Why is Perrigo Company plc going down?

PRGO stock is down 5.0% on Mar 12, 2026 15:55

  • The increased stake by institutional investors like Dimensional Fund Advisors LP and BW Gestao de Investimentos Ltda. could indicate confidence in Perrigo's long-term prospects, yet the market reacted negatively.
  • Despite the company's declaration of a quarterly dividend and analysts' "Hold" rating with a price target of $19.33, investors might be concerned about other factors impacting the stock.
  • The bearish movement could be attributed to broader market conditions, sector-specific challenges, or specific company developments not shared widely.
  • Investors may be reacting to potential risks or uncertainties surrounding Perrigo, leading to the downward pressure on the stock price despite the positive institutional investment activities.

PRGO Price Chart

PRGO Technical Analysis

PRGO News

Dimensional Fund Advisors LP Purchases 181,828 Shares of Perrigo Company plc $PRGO

Dimensional Fund Advisors LP increased its stake in Perrigo Company plc (NYSE:PRGO) by 2.4% in the third quarter, acquiring an additional 181,828 shares. This brings their total holdings to 7,695,238 shares, valued at $171.37 million, representing 5.59% of the company, with institutional investors owning 95.91% of the stock. Perrigo has also declared a quarterly dividend of $0.29 per share (11.2% yield) and received an average "Hold" rating from analysts with a $19.33 price target.

https://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-purchases-181828-shares-of-perrigo-company-plc-prgo-2026-03-10/

0 News Article Image Dimensional Fund Advisors LP Purchases 181,828 Shares of Perrigo Company plc $PRGO

BW Gestao de Investimentos Ltda. Purchases 112,595 Shares of Perrigo Company plc $PRGO

BW Gestao de Investimentos Ltda. increased its stake in Perrigo Company plc (NYSE:PRGO) by 7.7% in the third quarter, now owning 1,582,119 shares worth $35,234,000. Other institutional investors also adjusted their holdings in Perrigo, with 95.91% of the stock owned by hedge funds and institutions. The company recently reported its quarterly earnings, announcing a dividend of $0.29 per share, and analysts have issued various ratings and price targets for the stock.

https://www.marketbeat.com/instant-alerts/filing-bw-gestao-de-investimentos-ltda-purchases-112595-shares-of-perrigo-company-plc-prgo-2026-03-10/

1 News Article Image BW Gestao de Investimentos Ltda. Purchases 112,595 Shares of Perrigo Company plc $PRGO

Perrigo Company plc Price History

20.01.2026 - PRGO Stock was up 0.1%

  • The strong bullish movement in PRGO today can be attributed to the announcement of a quarterly dividend of $0.29 per share, showcasing the company's commitment to rewarding shareholders even amidst financial challenges.
  • Despite the expected decline in Q4 earnings and revenues, investors seem optimistic about Perrigo's future prospects, especially with a 44% upside potential according to valuation insights.
  • The focus on being a pure-play consumer health company and the emphasis on private-label offerings to invest in leading brands might have resonated positively with investors, driving the bullish sentiment in the stock today.

03.02.2026 - PRGO Stock was down 8.5%

  • Perrigo Company plc (PRGO) received a consensus "Hold" rating from analysts, with a lower-than-expected 12-month price target.
  • Despite increased stakes from major investors like Bahl & Gaynor Inc. and Vanguard Group Inc., Perrigo missed Q4 EPS estimates and issued weaker FY2026 guidance, citing challenges in the infant formula segment.
  • The company discussed its Q4 earnings, acknowledging temporary headwinds such as a soft cough and cold season and plant underabsorption, leading to a transition year in 2026.
  • Analysts, including Jefferies, maintained a "Hold" rating on PRGO, signaling a cautious approach and a wait-and-see attitude towards operational improvements.

05.00.2026 - PRGO Stock was up 1.9%

  • Perrigo's stock experienced a bullish movement despite facing multiple class action lawsuits related to its infant formula business.
  • Investors seem hopeful about Perrigo's ability to address the legal challenges and recover financially.
  • The positive stock performance could be due to expectations of Perrigo implementing corrective measures to improve transparency and governance.
  • There is a perception among investors that the lawsuits are temporary obstacles that Perrigo can overcome, bolstering confidence in the company's long-term outlook.

25.10.2025 - PRGO Stock was up 5.5%

  • Despite facing various legal challenges, PRGO stock showed a significant upward movement.
  • Investors may be interpreting potential advancements in the legal cases against Perrigo Company plc in a positive light.
  • The stock's bullish trend could also be influenced by market speculations or a change in investor sentiment driven by factors not explicitly mentioned elsewhere.
  • Staying informed about updates on legal proceedings and market dynamics is crucial for making well-informed decisions concerning PRGO stock.

05.10.2025 - PRGO Stock was down 21.4%

  • The decline in PRGO stock today may be linked to the revenue results for the quarter ending September 2025, which fell short of estimates by -4.84%.
  • Despite exceeding earnings estimates by +6.67%, the market's negative reaction to the revenue shortfall suggests apprehensions about the company's growth potential.
  • Concerns about PRGO stock's future performance may arise as the revenue miss could signal challenges to the company's financial health and stability.

26.01.2026 - PRGO Stock was down 1.1%

  • The bearish movement in Perrigo's stock price today could be attributed to the cautious outlook from analysts regarding the upcoming Q4 earnings, which is expected to show a decline in both EPS and revenue.
  • The planned divestiture of Perrigo's rare disease affiliate for $294 million could be seen as a strategic move to focus on its core consumer goods business, but investors might be concerned about the impact on future revenue streams.
  • Despite the positive news of a quarterly dividend announcement, the overall sentiment seems to be overshadowed by the upcoming earnings report and the company's recent performance, leading to the bearish market movement today.

04.01.2026 - PRGO Stock was up 5.5%

  • The announcement of Perrigo's strategic review of its infant formula business has sparked investor optimism and contributed to the bullish movement in PRGO stock.
  • Investors likely view this move as a proactive step towards enhancing Perrigo's overall portfolio and focusing on high-potential OTC products, which are more aligned with the company's strategic goals.
  • The decision to re-evaluate a significant investment in the infant formula business, coupled with the emphasis on accelerating cash flows, signals a commitment to optimizing resources and maximizing returns for shareholders.
  • By streamlining its operations and reallocating resources to areas with higher growth potential, Perrigo aims to strengthen its position in the market and drive long-term value creation, which has resonated positively with investors.

06.10.2025 - PRGO Stock was down 8.2%

  • PRGO posted Q3 earnings exceeding expectations but underperformed in sales, resulting in a mixed outcome.
  • Following a downward revision of its 2025 outlook and the initiation of a review of its infant formula unit, investor worries about future growth prospects were sparked, leading to a decline in the stock price.
  • Despite surpassing earnings expectations, PRGO faced a notable bearish movement in the stock market due to negative reactions to the uncertainty surrounding the company's strategic decisions.

19.10.2025 - PRGO Stock was down 5.1%

  • The securities fraud class action lawsuit filed against Perrigo Company plc might have created uncertainty and negative sentiment among investors, leading to a sell-off of PRGO shares.
  • The reminder to investors about the ongoing class action lawsuits against Perrigo Company plc could have further fueled concerns and prompted more selling pressure on the stock.
  • The legal challenges and potential financial implications from the lawsuits may have overshadowed any positive developments or fundamentals related to Perrigo Company plc, contributing to the bearish market movement of PRGO today.

12.02.2026 - PRGO Stock was down 5.0%

  • The increased stake by institutional investors like Dimensional Fund Advisors LP and BW Gestao de Investimentos Ltda. could indicate confidence in Perrigo's long-term prospects, yet the market reacted negatively.
  • Despite the company's declaration of a quarterly dividend and analysts' "Hold" rating with a price target of $19.33, investors might be concerned about other factors impacting the stock.
  • The bearish movement could be attributed to broader market conditions, sector-specific challenges, or specific company developments not shared widely.
  • Investors may be reacting to potential risks or uncertainties surrounding Perrigo, leading to the downward pressure on the stock price despite the positive institutional investment activities.

06.07.2025 - PRGO Stock was down 16.1%

  • Perrigo (PRGO) posted earnings and revenue figures for Q2 that fell below expectations, resulting in a decline in the stock price.
  • Despite the disappointing performance, financial analysts are bullish on Perrigo's future, anticipating a potential 36% increase in the stock price.
  • Investors are keeping a close eye on Perrigo's Q2 earnings release to glean insights into its Kairos deal and strategies for navigating macroeconomic pressures that may have contributed to the recent market downturn.

27.01.2026 - PRGO Stock was down 2.5%

  • PRGO stock experienced a significant bearish movement today, dropping by 6.7% in pre-market trading.
  • The bearish trend can be attributed to the Q4 2025 earnings report where both adjusted EPS and revenue missed analyst estimates, leading to investor disappointment.
  • Despite management highlighting strategic progress and market share gains, investors focused on the immediate financial shortfall, causing the stock price to decline.
  • The upcoming ex-dividend date and historical dividend charts may have influenced some investors to sell off their positions, contributing to the downward pressure on PRGO stock.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.